Pharma Equity Group A/S
CSE:PEG
Pharma Equity Group A/S
CSE:PEG
Price:
0.0936
DKK
0.21%
Market Closed
Market Cap:
kr114.9m
Pharma Equity Group A/S
Other
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Pharma Equity Group A/S
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharma Equity Group A/S
CSE:PEG
|
Other
-kr3.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jeudan A/S
CSE:JDAN
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Other
kr3.4m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
PEG
Intrinsic Value
0.0803
DKK
Overvaluation 14%
See Also
What is Pharma Equity Group A/S's Other?
Other
-3.2m
DKK
-3.2m
DKK
Based on the financial report for Jun 30, 2025, Pharma Equity Group A/S's Other amounts to -3.2m DKK.
What is Pharma Equity Group A/S's Other growth rate?
Other CAGR 1Y
82%
82%
Over the last year, the Other growth was 82%.
